Christian Wolfram
Overview
Explore the profile of Christian Wolfram including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vogl T, Nica A, Booz C, Alizadeh L, Becker S, Yel I, et al.
Medicina (Kaunas)
. 2024 Oct;
60(10).
PMID: 39459373
: This study aimed to evaluate the tumor response relating to and survival benefit of transarterial chemoperfusion (TACP) and transarterial chemoembolization (TACE) in the treatment of patients with unresectable gynecologic...
2.
Wolfram C
Klin Monbl Augenheilkd
. 2024 Feb;
241(2):154-161.
PMID: 38412979
Background: Epidemiological studies describe the distribution of glaucoma and its risk factors in the general population. Material And Methods: Epidemiological findings from population-based studies were extrapolated for the situation in...
3.
Wolfram C, Pfeiffer N, Hudde T, Klatt A, Schnegelsberg B, Ross M, et al.
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068487
Background: Retinal diseases such as neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), or branch/central retinal vein occlusion (B/CRVO) have significant implications for patients' social and psychological well-being. The...
4.
Wolfram C, Vu T, Klemm M, Spitzer M, Beuse A, Grohmann C
Ophthalmologie
. 2023 Oct;
120(11):1098-1106.
PMID: 37874364
Background: Glaucoma is a widespread ophthalmological disease. Knowledge about the spread of the disease in the population is necessary with respect to further questions on comorbidities, risk factors and the...
5.
Schuster A, Wolfram C, Hudde T, Klatt A, Schnegelsberg B, Midani-Oezkan H, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373576
Methods: An observational cohort study included patients with retinal diseases starting an intravitreal anti-vascular endothelial growth factor treatment in Germany. Treatment followed clinical practice except mandatory OCT examination during the...
6.
Wolfram C, Schuster A
Ophthalmologie
. 2022 Aug;
119(11):1140-1148.
PMID: 35925336
Background: The options for glaucoma treatment are quite diverse. The question therefore arises what is considered beneficial and feasible in daily practice. Our anonymized survey among members of the German...
7.
Thier A, Breuning M, Wolfram C, Zeitz O, Holmberg C
BMJ Open
. 2022 Jun;
12(6):e058266.
PMID: 35705348
Objectives: In order to better understand the continued barriers to the provision of vascular endothelial inhibitor therapy, this study aims to investigate patients' experiences with neovascular age-related macular degeneration (nvAMD)...
8.
Wolfram C, Schargus M
Ophthalmologe
. 2021 Aug;
119(3):280-287.
PMID: 34415380
Background: Intravitreal drug delivery belongs to the most common medical procedures, with approximately 1.5 million treatments per year in Germany. However, for this enormous challenge to provision of proper care,...
9.
Wolfram C, Schuster A
Ophthalmologe
. 2021 Mar;
119(1):38-45.
PMID: 33733713
Background: Glaucoma care has extended enormously in recent years. We performed a survey among the members of the German Ophthalmological Society (DOG) and the Professional Association of Ophthalmologists in Germany...
10.
Hajek A, Wolfram C, Spitzer M, Konig H
Aging Ment Health
. 2020 Feb;
25(5):946-953.
PMID: 32054296
Little is known about the specific association of vision loss and psychosocial outcome measures in contrast to other health limitations. The aim of this study was to identify whether vision...